Cryoport inc (CYRX)
Sector • Healthcare Industry • Major Pharmaceutical Preparations |
Industry • Major Pharmaceutical Preparations |
Sector • Healthcare |
News
Cryoport Inc Faces Challenges as Deficit Per Share Surges in Q4 2023
Cryoport Inc Reports Substantial Losses on Weak Sales Throughout Fiscal Second Quarter of 2023
Cryoport Inc Shows Promising Top-Line Growth in Q1 2023, but Sustainability Remains a Concern
An Ordinary Revenue advance for CYRX over the October to December 31 2022 period